Abstract
Anhedonia, a reduced ability to experience pleasure and lack of motivation, is a primary symptom of major depressive disorder (MDD) and often unresponsive to treatment. There is, however, evidence that ketamine has rapid-acting anti-anhedonic properties. To investigate mechanisms driving this effect, we examined how ketamine affects effort-based decision making. Since anhedonia has been associated with high subjective effort sensitivity, we predicted ketamine would decrease perceived effort costs in obtaining rewards.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have